Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Cysteinyl-tRNA Synthetase (CARS) (N-Term) Peptide

CARS Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN5511809

Aperçu rapide pour Cysteinyl-tRNA Synthetase (CARS) (N-Term) Peptide (ABIN5511809)

Antigène

CARS (Cysteinyl-tRNA Synthetase (CARS))

Origine

Humain

Source

  • 8
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Séquence

    ADSSGQQAPD YRSILSISDE AARAQALNEH LSTRSYVQGY SLSQADVDAF

    Attributs du produit

    This is a synthetic peptide designed for use in combination with anti-CARS Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    CARS (Cysteinyl-tRNA Synthetase (CARS))

    Sujet

    CARS is a class 1 aminoacyl-tRNA synthetase, cysteinyl-tRNA synthetase. Each of the twenty aminoacyl-tRNA synthetases catalyzes the aminoacylation of a specific tRNA or tRNA isoaccepting family with the cognate amino acid. CARS gene is one of several located near the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. Alternative splicing of this gene results in multiple transcript variants encoding distinct isoforms.

    Protein Size: 831

    ID gène

    833
Vous êtes ici:
Chat with us!